Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard E. Cutler
Author Correction: HER Kinase Inhibition in Patients With HER2- And HER3-mutant Cancers
Nature
Multidisciplinary
Extended Adjuvant Therapy With Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Cancer Discovery
Oncology
Outcomes of Chemotherapies and HER2 Directed Therapies in Advanced HER2-mutant Lung Cancers
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
HER3 Over-Expression and Overall Survival in Gastrointestinal Cancers
Oncotarget
Oncology
Novel Agents That Downregulate EGFR, HER2, and HER3 in Parallel
Oncotarget
Oncology
Author Correction: Genomic Characterization of Metastatic Breast Cancers
Nature
Multidisciplinary
Positive Prognostic Value of HER2-HER3 Co-Expression and P-mTOR in Gastric Cancer Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Inhibition of EGFR, HER2, and HER3 Signalling in Patients With Colorectal Cancer Wild-Type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): A Phase 2–3 Randomised Trial
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology
ZW25 Active in HER2-positive Cancers
Cancer Discovery
Oncology
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
